Education and Training
- Fellow in Hematology and Oncology, Medicine, Mount Sinai School of Medicine, 2004 - 2007
- Medical Resident, Medicine, Mount Sinai School of Medicine, 2001 - 2004
- M.D., University of Medicine and Dentistry of New Jersey, 2001
Chino, F, Peppercorn, JM, Rushing, C, Kamal, AH, Altomare, I, Samsa, G, and Zafar, SY. "Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care." JAMA oncology 3, no. 11 (November 2017): 1582-1584.
Li, S, Molony, JT, Cetin, K, Wasser, JS, and Altomare, I. "Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study." Current Medical Research and Opinion (August 24, 2017): 1-8.
Lin, J, Zhang, X, Li, X, Chandler, D, Altomare, I, Wasser, JS, and Cetin, K. "Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States." Clinical therapeutics 39, no. 3 (March 2017): 603-609.e1.
Altomare, I, Irwin, B, Zafar, SY, Houck, K, Maloney, B, Greenup, R, and Peppercorn, J. "Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care." Journal of oncology practice 12, no. 3 (March 2016): e281-248.
Zafar, SY, Chino, F, Ubel, PA, Rushing, C, Samsa, G, Altomare, I, Nicolla, J, Schrag, D, Tulsky, JA, Abernethy, AP, and Peppercorn, JM. "The utility of cost discussions between patients with cancer and oncologists." The American journal of managed care 21, no. 9 (September 2015): 607-615.
Cines, DB, Gernsheimer, T, Wasser, J, Godeau, B, Provan, D, Lyons, R, Altomare, I, Wang, X, and Lopez, A. "Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim." International journal of hematology 102, no. 3 (September 2015): 259-270.
Liu, Y, Starr, MD, Brady, JC, Rushing, C, Bulusu, A, Pang, H, Honeycutt, W, Amara, A, Altomare, I, Uronis, HE, Hurwitz, HI, and Nixon, AB. "Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus." Molecular cancer therapeutics 14, no. 4 (April 2015): 1048-1056.
Nussbaum, N, and Altomare, I. "The neoadjuvant treatment of rectal cancer: a review." Current oncology reports 17, no. 3 (March 2015): 434-. (Review)
Selleslag, D, Bird, R, Altomare, I, Giagounidis, A, Janssens, A, Pabinger, I, Pullarkat, V, Wei, H, and Kreuzbauer, G. "Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider." European journal of haematology 94, no. 2 (February 2015): 169-176.
Irwin, B, Kimmick, G, Altomare, I, Marcom, PK, Houck, K, Zafar, SY, and Peppercorn, J. "Patient experience and attitudes toward addressing the cost of breast cancer care." November 2014.